Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis

Turkish Journal of Pediatrics

Volumn 38, Issue 2, 1996, Pages 155-159

  Varan, Birgül ^a   Saatçi, Ümit ^a   Özen, Seza ^a   Bakkaloǧlu, Ayşin ^a   Beşbaş, Nesrin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

enuresis; indomethacin; oxybutynin; pseudoephedrine

Indexed keywords

INDOMETACIN; OXYBUTYNIN; PSEUDOEPHEDRINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EPISTAXIS; FLUSHING; HUMAN; NOCTURNAL ENURESIS; SIDE EFFECT; VERTIGO;

ADRENERGIC ALPHA-AGONISTS; CHILD; CHOLINERGIC ANTAGONISTS; CYCLOOXYGENASE INHIBITORS; ENURESIS; EPHEDRINE; HUMANS; INDOMETHACIN; MANDELIC ACIDS; TREATMENT OUTCOME;

EID: 0030009970     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Oppel WC, Harper PA, Rider RV. The age of attaining bladder control. Pediatrics 1968; 42: 614-626.
2. Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Arch Dis Child 1974; 49: 259-263.
3. Scharf MB, Pravda MF, Jenings SW, et al. Childhood enuresis: a comprehensive treatment programme. Psychiatr Clin North Am 1987; 10: 655-666.
4. McLorie GA, Husmann DA. Incontinence and enuresis. Pediatr Clin North Am 1987; 34: 1159-1174.
5. Zaleski A, Gerrad JW, Shokeir MHK. Nocturnal enuresis: the importance of a small bladder capacity. In: Kolvin I, Mac Keith RC, Meadow SR (eds). Bladder Control and Enuresis. London: Heinemann Medical Books; 1973: 95-101.
6. Hallman N. On the ability of enuretic children to hold urine. Acta Paediatr 1950; 39: 87-93.
7. Webster GD, Koefoot RB Jr, Sihelnik S. Urodynamic abnormalities in neurologically normal children with micturition dysfunction. J Urol 1984; 132: 74-77.
8. Rushton HG, Nocturnal enuresis: epidemiology, evaluation, and currently available treatment options. J Pediatr 1989; 114: 691-696.
9. Schmitt BD. Nocturnal enuresis: an update on treatment. Pediatr Clin North Am 1982; 29: 21-36.
10. Brown JH. Atropine. Scopolamine and related antimuscarinic drugs. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: Pergamon Press; 1990: 160.
11. Buttarazi PJ. Oxybutynin chloride (Ditropan) in enuresis. J Urol 1977; 118: 46.
12. Lovering JS, Tallett SE, McKendry JB. Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics 1988; 82: 104-106.
13. Husted S, Sjögren C, Anderson KE. Role of prostaglandins in the responses of rabbit detrusor to non-cholinergic, non-adrenergic nerve stimulation and to ATP. Arch Int Pharmacodyn Ther 1980; 246: 84-97.
14. Anderson RJ, Berl T, McDonald KM, Schrier RW. Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest 1975; 56: 420-426.
15. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984; 310: 563-572.
16. AL-Waili NS. Diclofenac sodium in the treatment of primary nocturnal enuresis: double-blind crossover study. Clin Exp Pharmacol Physiol 1986; 13: 139-142.
17. Metin A, Aykol N. Diclofenac sodium suppository in the treatment of primary nocturnal enuresis. Int Urol Nephrol 1992; 24: 113-117.
18. AL-Waili NS. Indomethacin suppository to treat primary nocturnal enuresis: double blind study. J Urol 1989; 142: 1290-1292.
19. Hoffman BB, Lefkowitz RJ. Catecholamines and sympathomimetic drugs. In: Gilman AG, Rall TW, Nies AS, Taylor P. (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: Pergamon Press; 1990: 196.
20. Ress DL, Ransley PG. Eskornade in the treatment of diurnal incontinence in children. Br J Urol 1980; 52: 476-479.
21. Barton JL, Felker JR. Daytime enuresis. Br J Psychiatry 1982; 140: 325.